• SPX
  • $5,985.38
  • 0.02 %
  • $1.39
  • DJI
  • $43,958.19
  • 0.11 %
  • $47.21
  • N225
  • $38,761.02
  • 0.1 %
  • $39.36
  • FTSE
  • $8,030.33
  • 0.06 %
  • $4.56
  • IXIC
  • $19,230.74
  • -0.26 %
  • -$50.66

Eli Lilly plans to begin advertising weight-loss drug Zepbound

By Yahoo! Finance   |   Oct 30, 2024 at 12:58 PM EST
Eli Lilly plans to begin advertising weight-loss drug Zepbound

Eli Lilly plans to advertise its weight loss drug Zepbound for the first time to increase awareness. Despite missing sales expectations, the company aims to boost patient awareness and market share against competitors like Novo Nordisk.

Read More

Did you find this insightful?


We are preparing, please wait

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.